Literature DB >> 6146509

Direct beta-adrenergic stimulation of aldosterone secretion in cultured bovine adrenal subcapsular cells.

A De Léan, K Racz, N McNicoll, M L Desrosiers.   

Abstract

Primary culture of bovine adrenal subcapsular cells was used to investigate direct effects of catecholamines on aldosterone secretion. Cells dispersed with collagenase and DNAse and cultured at high density (1.5-2 million/ml) for 3 days displayed high sensitivity to angiotensin II and ACTH, with an ED50 of 1.4 and 1.5 nM, respectively. Adrenergic agonists elicited a 4- to 6-fold stimulation of aldosterone secretion with potency order (-)isoproterenol greater than (-)epinephrine equals (-)norepinephrine greater than (+)isoproterenol, and corresponding ED50 5, 240, 213, and 3000 nM, respectively. No reproducible inhibition by dopamine of basal or stimulated levels of aldosterone secretion could be detected, but a weak stimulatory effect was sometimes observed at high concentration greater than 10 microM. (-)Isoproterenol stimulation of aldosterone production was potently inhibited by the beta-adrenergic antagonists (-)alprenolol and (+)alprenolol with potencies of 1.8 and 110 nM, respectively. The alpha-adrenergic antagonists prazosin, yohimbine, and phentolamine only weakly inhibited (-)isoproterenol stimulation with potencies of 5, 13, and 140 microM, respectively. The potent beta 2-adrenergic antagonist ICI 118.551 and the weaker beta 1-adrenergic antagonist atenolol were roughly equipotent with potencies of 0.27 and 0.44 microM, respectively. Addition of the phosphodiesterase inhibitor Ro 20-1724 at 10 microM doubled the maximum stimulation effect of (-)isoproterenol without changing the potency of the catecholamine or the basal level of aldosterone secretion, suggesting a potential role of cAMP as a mediator of isoproterenol stimulation. These results indicate the presence of a beta 1-adrenergic receptor stimulating aldosterone secretion in bovine zona glomerulosa cells. The physiological significance of direct beta-adrenergic stimulation of aldosterone production is currently being assessed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146509     DOI: 10.1210/endo-115-2-485

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  BK channels and a new form of hypertension.

Authors:  P Richard Grimm; Steven C Sansom
Journal:  Kidney Int       Date:  2010-08-18       Impact factor: 10.612

Review 3.  Autonomic control of adrenal function.

Authors:  A V Edwards; C T Jones
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

4.  Effects of β-adrenergic receptor agonists on drinking and arterial blood pressure in young and old rats.

Authors:  Robert L Thunhorst; Connie L Grobe; Terry G Beltz; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-09       Impact factor: 3.619

5.  Morphological evidence for a close interaction of chromaffin cells with cortical cells within the adrenal gland.

Authors:  S R Bornstein; M Ehrhart-Bornstein; H Usadel; M Böckmann; W A Scherbaum
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

6.  Hyperreninemic hypoaldosteronism after chronic stress in the rat.

Authors:  G Aguilera; A Kiss; B Sunar-Akbasak
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Subclassification of beta-adrenoceptors responsible for steroidogenesis in primary cultures of bovine adrenocortical zona fasciculata/reticularis cells.

Authors:  E R Lightly; S W Walker; I M Bird; B C Williams
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

Review 8.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.